MS Jennifer M. Polinski MPH

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A fter years of debate about the role of the marketplace, consumerism, and the government in providing prescription drug benefits to seniors, evaluations of Medicare Part D are beginning to trickle in. Despite controversy about the design and complexity of the Part D benefit, evidence suggests that the program has successfully enhanced drug coverage for(More)
  • 1